The NATCO CL fallout

The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market

A patent triumph of public interest

New flexibilities make public interest safeguards integral to drug patent rights

The natco-pfizer test

Natco’s demand for a voluntary licence from Pfizer will establish how well the compulsory licence process works in India

Drug affordability test

Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …

Profits and not improving accessibility matter to Indian drug makers

FICCI conference organised to discuss access to generic medicines focuses more on increasing exports

Ranbaxy effect: Indian government defends pharma industry

Few isolated cases cannot undermine well regulated system, says commerce ministry

'India’s drug dependence on China not good for its health sector'

Setting up of large-scale pharma and chemical clusters in proximity to each other can help sector perform better, says industry body ASSOCHAM

New hepatitis drug to cost more in middle income nations; activists cry foul

Pharma company’s strategy of different prices for different countries to affect quality treatment of 185 million people infected with …

Modi Cabinet approves 100% FDI in medical devices sector via automatic route

Existing conditions and prior approval required in case of merger and acquisition done away with

That which is injurious to health

Book>> Bad Pharma • by Ben Goldacre • Fourth Estate • £13

Ban FDI in brownfield pharma, says Parliament standing committee

Panel raises alarm over continuing takeover of Indian generic drug firms by multinational companies

Maharashtra bans anti-tick medication temporarily

26 heads of cattle killed after being administered injection in Parbhani district

CAG exposes land scam in Andhra

Government largesse to private enterprises and individuals cost exchequer Rs 1,784 crore

Karnataka receives lowest solar energy tariff bid till date

Sun Pharma bags solar project by quoting Rs 5.51 per unit; previous lowest bid was for Rs 7 in Odisha

Three pharma units under scanner for exposing workers to polyacrylate hazard

Gujarat High court directs medical check-up of all employees

Will appellate body uphold grant of compulsory licence to cancer drug?

Hearing on Bayer's appeal against manufacture of generic version of Nexavar to conclude this week

Indian company gets licence to manufacture and sell patented cancer drug

This is the first-ever compulsory licence given to a generic drug company

India: the pharmacy of the world where ‘crazy drug combinations’ go unregulated

Of 175 drug combinations used to treat pain-relief, diabetes, anxiety/depression, and psychosis, a study found that 115 combinations had no …

Government stand against EU ban on Indian drugs much needed, says industry

Standing against the arbitrary ban on 700 drugs, India has decided to defer the proposed talks on the free trade agreement between India and the EU

India to set up 10 pharma clusters across country

The move will reduce cost of production of medicines by up to 25 per cent

FDI in pharma: Cabinet clears KKR investments in two Indian drug firms

Union health and commerce ministries have been opposing such investment without safeguards for acquisition of domestic critical care pharma firms

Sun Pharma to buy troubled giant Ranbaxy

The combined entity will create India’s largest pharma company and world’s fifth-largest specialty generics company

Sun-Ranbaxy merger: CCI says deal may hurt competition, seeks public opinion

The merger would lead to creation of the world's fifth-largest maker of generic drugs

Sun Pharma, Novartis settle lawsuit over Glivec

Sun Pharma allowed to launch generic version of anti-leukamia drug next year

No veterinary drug given to Jodhpur hospital; just a case of wrong labelling, says company

Rajasthan government sets up committee to probe administration of injections from vials labelled 'for animal treatment'